Company intelligence / Profile preview

Biopharma PEG

Watertown, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Biopharma PEG is a leading supplier and manufacturer of high-quality polyethylene glycol (PEG) derivatives and related services for the pharmaceutical and biotechnology industries. The company specializes in the development and production of monodisperse and polydisperse PEGs, ADC linkers, PROTAC linkers, and lipid excipients used in mRNA-LNP delivery systems. Based in Watertown, Massachusetts, Biopharma PEG supports drug discovery and development through custom synthesis and scale-up manufacturing. Their products are essential for improving the solubility, stability, and pharmacokinetics of various therapeutic modalities, including proteins, peptides, and small molecules.

Modalities: Antibody-drug conjugateProteolysis-targeting chimera therapyLipid nanoparticle delivery therapymRNA-based drugsPeptidesPolymer-drug conjugate therapy
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Biopharma PEG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopharma PEG.

Explore the full profile